News and Announcements
YPB Extends e-Passport Agreement
- Published August 17, 2016 2:45PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th August 2016, ASX Announcement
Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has exercised the option to extend the Memorandum of Cooperation (MOC) with Foilmakers Australia Pty Ltd (FMA) relating to the application of proprietary VariSec technology to e-Passports.
Singed in July 2015, the first year of the agreement has resulted in four order including re-orders for YPB’s VariSec technology, to be applied to newly issued e-Passports for both first world and emerging economies. Continued orders are expected over the next 12 months.
YPB’s VariSec technology has now been applied to three countries’ e-Passport in a marketplace where an estimated 125 million new e-Passports in a marketplace where an estimated 125 million new e-Passports are issued annually.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
